Lyophilized Herpes Zoster Virus mRNA Vaccine (Sinovac Biotech)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameLyophilized Herpes Zoster Virus mRNA Vaccine (Sinovac Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinovac Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes Zoster
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A